These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. Parise LV, Venton DL, Le Breton GC. J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669 [Abstract] [Full Text] [Related]
23. Purification and characterization of the human platelet TXA2/PGH2 receptor. Narumiya S, Ushikubi F, Nakajima M, Hirata M, Okuma M. Adv Prostaglandin Thromboxane Leukot Res; 1991 Jan; 21A():339-46. PubMed ID: 1825566 [No Abstract] [Full Text] [Related]
24. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets]. Basevich VV, Mevkh AT, Varfolomeev SD. Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597 [Abstract] [Full Text] [Related]
25. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets. Halushka PV, Kochel PJ, Mais DE. Br J Pharmacol; 1987 May; 91(1):223-7. PubMed ID: 3594077 [Abstract] [Full Text] [Related]
26. The binding of [3H]9,11-dideoxy,9 alpha-11 alpha-methanoepoxy prostaglandin F2 alpha (U 46619) to washed human platelets. Jaschonek K, Faul C, Weisenberger H, Schmidt H, Renn W. Prog Clin Biol Res; 1989 May; 301():327-33. PubMed ID: 2529551 [No Abstract] [Full Text] [Related]
27. Biosynthesis and pharmacological modulation of thromboxane in humans. Patrono C. Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814 [Abstract] [Full Text] [Related]
28. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Fonlupt P, Croset M, Lagarde M. Thromb Res; 1991 Jul 15; 63(2):239-48. PubMed ID: 1837628 [Abstract] [Full Text] [Related]
29. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes. Mais DE, Saussy DL, Magee DE, Williams CM. Adv Prostaglandin Thromboxane Leukot Res; 1991 Jul 15; 21A():347-50. PubMed ID: 1825567 [No Abstract] [Full Text] [Related]
30. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG, Dellweg H, Perzborn E, Gross R. Biochem Pharmacol; 1992 Aug 04; 44(3):495-503. PubMed ID: 1387312 [Abstract] [Full Text] [Related]
31. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition. Patscheke H, Hornberger W, Zehender H. Z Kardiol; 1990 Aug 04; 79 Suppl 3():151-4. PubMed ID: 2099038 [Abstract] [Full Text] [Related]
32. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Morinelli TA, Naka M, Masuda A, Oatis JE, Okwu AK, Mais DE, Saussy DL, Halushka PV. Adv Prostaglandin Thromboxane Leukot Res; 1991 Aug 04; 21A():331-7. PubMed ID: 1825565 [No Abstract] [Full Text] [Related]
33. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes. Halushka PV, Boehm A, Mais DE. Eicosanoids; 1988 Aug 04; 1(1):41-4. PubMed ID: 2856171 [Abstract] [Full Text] [Related]
34. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate. Hornberger W, Patscheke H. Eicosanoids; 1989 Aug 04; 2(4):241-8. PubMed ID: 2517034 [Abstract] [Full Text] [Related]
35. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). Kattelman EJ, Venton DL, Le Breton GC. Thromb Res; 1986 Feb 15; 41(4):471-81. PubMed ID: 3008368 [Abstract] [Full Text] [Related]
36. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Liel N, Nathan I, Yermiyahu T, Zolotov Z, Lieberman JR, Dvilansky A, Halushka PV. Thromb Res; 1993 May 01; 70(3):205-10. PubMed ID: 8327985 [Abstract] [Full Text] [Related]
37. Characterization of thromboxane receptors in human platelets. Jones RL, Wilson NH, Armstrong RA. Adv Exp Med Biol; 1985 May 01; 192():67-81. PubMed ID: 3010674 [No Abstract] [Full Text] [Related]
38. Preparation and biological evaluation of a potential photoaffinity label for the prostaglandin H2/thromboxane A2 receptor. Arora SK, Kattelman EJ, Lim CT, Le Breton GC, Venton DL. J Med Chem; 1987 May 01; 30(5):918-24. PubMed ID: 2952799 [Abstract] [Full Text] [Related]
39. Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation. Modesti PA, Colella A, Cecioni I, Costoli A, Biagini D, Migliorini A, Neri Serneri GG. Am Heart J; 1995 May 01; 129(5):873-9. PubMed ID: 7732975 [Abstract] [Full Text] [Related]
40. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist. Hanasaki K, Arita H. Biochim Biophys Acta; 1989 Sep 04; 1013(1):28-35. PubMed ID: 2528990 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]